Korro Bio (KRRO) Assets (2018 - 2026)

Korro Bio (KRRO) has reported Assets for 9 consecutive years, with $163.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets fell 9.41% year-over-year to $163.4 million; the trailing twelve-month figure through Jun 2026 stood at $163.4 million (down 9.41% YoY), and the FY2025 full-year result was $113.5 million, down 49.83% from the prior year.
• Assets retreated to $163.4 million in Q2 2026 per KRRO's latest filing, from $183.6 million in the prior quarter.
• Across five years, Assets topped out at $249.6 million in Q2 2024 and bottomed at $46.3 million in Q3 2023.
• Historically, Assets has averaged $160.9 million across 5 years, with a median of $164.2 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Assets slumped 65.92% in 2023, then jumped 425.45% in 2024.
• Over 5 years, Assets stood at $73.7 million in 2022, then surged by 200.59% to $221.7 million in 2023, then grew by 2.06% to $226.2 million in 2024, then slumped by 49.83% to $113.5 million in 2025, then jumped by 44.0% to $163.4 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $163.4 million, $183.6 million, and $113.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.